Mr. Wiboon Rasmeepaisarn

Independent Director

  • Member of the Risk Management Committee
Age
  • 61 years
Appointment Date
  • 12 May 2011
Family Relationship between Directors and Executives
  • - None -
Education
  • Master of Business Administration Thammasat University
  • Bachelor of Accounting Chulalongkorn University
Training Courses

Training Courses by Thai Institute of Directors:

  • Director Accreditation Program Class 28/2004
  • Director Certification Program Class 147/2011
  • Role of the Compensation Committee Class 13/2011
  • Monitoring Fraud Risk Management Class 8/2012
  • Monitoring of the Quality of Financial Reporting Class 16/2012
  • Monitoring the Internal Audit Function Class 13/2012
  • Monitoring system of Internal Control and Risk Management Class 13/2012
  • Audit Committee Program Class 41/2012
  • Anti-Corruption for Executive Program Class 13/2014
  • Role of the Chairman Program Class 35/2014
  • Corporate Secretary Program (CSP) Class 132/2022
Working Experience in the 5 Preceding Years
Listed Company

2015 - Present

  • Member of the Audit Committee / Member of the Risk Management Committee / Member of the Nomination and Remuneration Committee
    Ananda Development PCL. / Real estate development and management services for real estate projects

2018 – Present

  • Chairman of the Audit Committee
    Mena Transport PCL. / Transportation Business

2003 - Present

  • Member of the Risk Management Committee
    NFC Public Company Limited / Chemical product warehouse wharf and distribution of fertilizers
Non - Listed Company

2009 – Present

  • Director
    Eltek Power Co., Ltd. / Importer, distributor, and installation of new electronic devices and technology and equipment on telecommunications.

1992 – Present

  • Director and Managing Director
    Warach Paisarn Co., Ltd. / Auditing services

2021 – Present

  • Executive Director
    Professional Laboratory Management Corp Plc. / Medical Laboratory

2021 – Present

  • Executive Director
    Sanus Technology Co., Ltd. / Manufacture and sale of drugs, pharmaceuticals, pharmaceuticals, and chemicals for medical use
Shareholding as of 31 December 2022
  • - None -